remyelin
phenomenon
new
myelin
sheath
gener
around
axon
adult
central
nervou
system
cn
follow
patholog
loss
myelin
diseas
like
multipl
sclerosi
ms
remyelin
restor
conduct
properti
axon
therebi
restor
neurolog
function
increasingli
believ
exert
neuroprotect
role
axon
remyelin
occur
mani
ms
lesion
becom
increasingli
incompleteinadequ
eventu
fail
major
lesion
patient
evort
understand
caus
failur
regener
fuel
research
biolog
remyelin
complex
interdepend
cellular
molecular
factor
regul
process
examin
mechan
repair
experiment
lesion
demonstr
remyelin
occur
two
major
phase
first
consist
colon
lesion
oligodendrocyt
progenitor
cell
opc
second
diverenti
opc
myelin
oligodendrocyt
contact
demyelin
intern
review
neurobiolog
vol
axon
gener
function
myelin
sheath
sever
intracellular
extracellular
molecul
identifi
mediat
two
phase
repair
theoret
repair
demyelin
lesion
promot
enhanc
intrins
repair
process
provid
one
remyelinationenhanc
factor
via
immunoglobulin
therapi
altern
endogen
repair
bypass
introduc
myelinogen
cell
demyelin
area
sever
cellular
candid
identifi
mediat
repair
experiment
demyelin
lesion
futur
challeng
confront
therapeut
strategi
enhanc
remyelin
involv
translat
find
basic
scienc
clinic
demyelin
diseas
remyelin
exampl
spontan
repair
adult
central
nervou
system
cn
new
myelin
sheath
gener
around
demyelin
axon
follow
patholog
loss
myelin
occur
demyelin
diseas
notabl
multipl
sclerosi
ms
remyelin
provid
except
primari
tenet
neurosci
name
adult
cn
poor
intrins
capac
repair
follow
trauma
summar
cajal
famou
postul
everyth
may
die
noth
may
regener
cn
cajal
phenomenon
remyelin
document
earli
morpholog
descript
brain
ms
patient
marburg
plaqu
freshli
isol
cn
tissu
easili
identifi
distinct
discolor
area
myelin
loss
addit
classic
plaqu
sharpli
delin
area
reduc
myelin
densiti
observ
recogniz
evenli
distribut
pale
myelin
stain
repres
markschattenherd
shadow
plaqu
schlesing
fig
observ
attribut
initi
incomplet
demyelin
due
ongo
evolut
lesion
earlier
suggest
process
repair
could
follow
damag
myelin
marburg
despit
verif
spontan
remyelin
could
follow
myelin
loss
provid
till
pioneer
ultrastructur
studi
use
method
cerebrospin
fluid
csf
barbotag
induc
demyelin
clearli
demonstr
demyelin
axon
adult
cat
spinal
cord
acquir
new
myelin
sheath
bung
et
al
follow
earlier
observ
light
microscop
studi
myelin
reappear
time
anim
show
recoveri
partial
paralysi
bung
bung
settlag
suggest
thin
myelin
lamella
observ
demyelin
lesion
could
repres
area
spontan
remyelin
came
ultrastructur
studi
ms
plaqu
perier
gregoir
furthermor
studi
prove
remyelin
induc
structur
recoveri
also
allow
axon
regain
conduct
properti
smith
et
al
neurolog
function
lost
consequ
demyelin
jeveri
remyelin
larg
medium
diamet
cn
axon
easili
identifi
histolog
although
unequivoc
identif
remyelin
small
diamet
axon
gener
challeng
even
imposs
remyelin
axon
display
distinguish
featur
chief
among
shorten
length
new
internod
newli
gener
myelin
sheath
also
thinner
normal
therefor
relationship
myelin
thick
internod
length
axon
diamet
appli
normal
myelin
axon
pertain
remyelin
axon
either
experiment
lesion
ms
shadow
plaqu
despit
remyelin
allow
axon
regain
adequ
secur
conduct
properti
conduct
abnorm
record
remyelin
axon
includ
restor
latent
period
axon
normal
smith
et
al
smith
et
al
fig
section
brain
ms
patient
stain
luxol
fast
blue
identifi
subcort
white
matter
wm
green
arrow
indic
three
area
myelin
loss
repres
foci
chronic
demyelin
red
arrow
indic
area
pale
myelin
stain
repres
shadow
plaqu
remyelin
occur
illustr
key
point
spontan
remyelin
occur
eycient
ms
process
fail
mani
occas
leav
axon
chronic
demyelin
reproduc
permiss
adam
data
extent
distribut
remyelin
ms
mainli
obtain
postmortem
tissu
obviou
problem
interpret
data
repres
static
pictur
ms
lesion
therefor
provid
clue
degre
pattern
repair
dynam
evolv
lesion
exist
clinic
diseas
clinic
magnet
reson
imag
mri
gener
consid
sensit
method
detect
alter
white
matter
wm
ms
patient
identif
remyelin
lesion
far
larg
unreli
advanc
multicontrast
mri
increasingli
allow
character
monitor
remyelin
ms
patient
merkler
et
al
extent
remyelin
observ
ms
lesion
highli
variabl
accompani
signific
variat
plaqu
size
diver
pattern
demyelin
oligodendrocyt
damageloss
may
depend
degre
stage
progress
lesion
may
also
relat
variat
underli
pathogen
mechan
lucchinetti
et
al
gener
degre
remyelin
ms
lesion
correl
directli
number
oligodendrocyt
express
myelin
protein
mrna
macrophag
lesion
lucchinetti
et
al
remyelin
occur
rapidli
thin
short
internod
detect
acut
lesion
within
week
lesion
genesi
remyelin
occur
concomit
tissu
infiltr
macrophag
ghatak
et
al
lassmann
prinea
et
al
prinea
et
al
occasion
myelin
destruct
lassmann
et
al
prinea
et
al
rain
wu
convers
remyelin
lesion
undergo
activ
demyelin
prinea
et
al
result
new
lesion
overlap
remyelin
area
shadow
plaqu
commonli
observ
young
patient
activ
relapsingremit
cours
older
patient
inact
chronic
one
prinea
connel
chronic
lesion
patient
longstand
diseas
tend
show
spars
remyelin
restrict
thin
rimbord
periplaqu
white
matter
ppwm
addit
remyelin
may
spars
case
primari
progress
ms
lassmann
et
al
remyelin
central
axon
sometim
accompani
schwann
cell
invas
cn
itoyama
et
al
common
near
peripher
nerv
root
entri
exit
zone
spinal
cord
found
promin
featur
japanes
patient
itoyama
et
al
convent
assum
remyelin
schwann
cell
origin
schwann
cell
associ
spinal
root
nerv
suppli
vasculatur
mening
schwann
cell
remyelin
gener
promin
area
astrocyt
oligodendrocyt
loss
lead
suggest
death
astrocyt
constitut
glia
limitan
allow
schwann
cell
entri
cn
reorgan
structur
would
inhibit
influx
challeng
view
report
suggest
instead
remyelin
schwann
cell
may
deriv
cn
precursor
await
formal
proof
blakemor
extent
remyelin
associ
diver
clinic
outcom
diseas
sever
recoveri
ms
current
unclear
suggest
remyelin
unlik
play
signific
role
earli
remiss
conduct
deficit
persist
earli
stage
remiss
may
import
later
stage
function
recoveri
jone
remyelin
fail
lesion
ms
like
numer
causal
factor
underli
progress
clinic
deterior
diseas
inadequaci
failur
remyelin
like
play
signific
contributori
role
perman
neurolog
dysfunct
observ
ms
tradit
attribut
demyelin
recent
clinic
studi
question
valid
assumpt
grow
belief
perman
axon
loss
like
patholog
correl
irrevers
function
deficit
fig
demyelin
axon
may
vulner
damag
acut
phase
possibl
damag
plu
atrophi
chronic
phase
ms
ferguson
et
al
lova
et
al
trapp
et
al
caus
axon
atrophi
unclear
demyelin
may
predispos
axon
secondari
injuri
multipl
molecular
cytotox
mechan
includ
ion
channel
dysfunct
mitochondri
damag
failur
local
targetderiv
neurotroph
support
myelin
oligodendrocyt
impli
one
princip
function
myelin
protect
axon
secondari
insult
rodriguez
waxman
date
formal
proof
remyelin
prevent
axon
atrophi
loss
howev
axon
loss
experiment
allerg
encephalomyel
eae
lesion
greater
demyelin
area
remyelin
one
kornek
et
al
addit
absenc
proteolipid
protein
plp
major
myelin
protein
result
progress
axon
degener
rodent
human
garbern
et
al
griffith
et
al
edgar
et
al
mice
lack
cyclic
nucleotid
phosphodiesteras
cnp
enzym
express
oligodendrocyt
also
show
sever
axon
degener
accumul
amyloid
precursor
protein
app
associ
signific
motor
deficit
becom
manifest
month
lappesiefk
et
al
clear
oligodendrocyt
maintain
axon
integr
oligodendroglia
express
ngf
bdnf
key
neurotroph
factor
play
role
mainten
surviv
neuron
opc
diverenti
oligodendrocyt
also
support
neuron
surviv
contactmediatedsolubl
mechan
provid
potenti
mechan
remyelin
could
prevent
neuron
atrophi
byravan
et
al
wilkin
et
al
secur
electr
conduct
axon
made
possibl
defin
organ
cellular
process
domainspecif
ion
channel
node
ranvier
review
sherman
brophi
remyelin
support
develop
matur
new
node
central
axon
display
appar
normal
ion
channel
distribut
dugandzijanovakov
et
al
sasaki
et
al
find
add
support
known
role
remyelin
restor
conduct
properti
axon
strategi
aim
promot
cn
remyelin
therefor
predict
restor
secur
conduct
therebi
promot
function
recoveri
protect
axon
inflammatori
lesion
secondari
injuri
sever
model
experiment
demyelin
current
use
autoimmun
model
demyelin
jointli
refer
eae
model
mani
variant
model
consist
immun
genet
suscept
anim
direct
inject
myelin
antigen
myelin
basic
two
option
follow
demyelin
multipl
sclerosi
either
remyelin
take
place
axon
preserv
b
axon
death
may
ensu
either
due
rang
cytotox
mechan
due
failur
local
neurotroph
support
due
glial
cell
injuri
remyelin
like
occur
recruit
opc
demyelin
area
subsequ
matur
myelin
cell
modifi
permiss
rodriguez
protein
mbp
myelinassoci
glycoprotein
mag
plp
myelin
oligodendrocyt
glycoprotein
mog
altern
cell
sensit
myelin
antigen
transfer
passiv
anim
adopt
transfer
eae
lesion
display
mani
patholog
featur
ms
lesion
term
dissemin
demyelin
infiltr
macrophag
cell
signific
similar
observ
clinic
cours
eae
ms
kornek
et
al
storch
et
al
extent
axon
loss
eae
lesion
also
correl
chronic
neurolog
deficit
papadopoulo
et
al
acut
chronic
form
diseas
induc
eae
model
well
relapsingremit
progress
form
review
ercolini
miller
target
model
eae
describ
kerschenstein
et
al
subthreshold
immun
lewi
rat
myelin
antigen
combin
inject
cytokin
like
ifnand
tnf
focal
cn
site
creat
singl
prototyp
inflammatori
lesion
defin
cn
foci
lesion
share
patholog
featur
ms
lesion
addit
advantag
eas
lesion
local
refin
behavior
test
also
carri
anim
anoth
model
antibodymedi
demyelin
produc
focal
inject
antigalactocerebrosid
galc
antibodi
plu
complement
specif
cn
site
keirstead
et
al
virus
caus
cn
demyelin
review
ercolini
miller
wide
studi
model
demyelin
base
infect
mice
theiler
murin
encephalomyel
viru
tmev
inject
cn
certain
mous
strain
viru
induc
demyelin
lesion
associ
viru
replic
oligodendrocyt
low
neurovirul
strain
like
da
bean
caus
biphas
diseas
mice
irrelev
matter
disk
file
earli
phase
consist
subleth
enceph
later
phase
consist
viral
infect
inflammatori
cell
astrocyt
oligodendrocyt
multifoc
demyelin
axon
damag
depend
mous
strain
use
review
oleszak
et
al
experiment
demyelin
multipl
foci
induc
jhm
strain
mous
hepat
viru
mhv
coronaviru
mice
follow
extens
remyelin
semliki
forest
viru
smv
also
induc
cn
demyelin
mice
mani
toxinmedi
model
demyelin
use
current
one
approach
consist
system
administ
agent
like
cuprizon
copperchel
agent
diet
laboratori
mice
model
disadvantag
associ
direct
toxin
inject
cn
like
cn
trauma
disrupt
bloodbrain
barrier
inflammatori
respons
occurr
demyelin
lesion
may
entir
reproduc
dose
use
current
stidworthi
et
al
model
consist
focal
microinject
toxin
like
ethidium
bromid
eb
r
lysolecithin
defin
cn
foci
fig
inj
ec
io
n
f
eb
r
es
ul
ts
death
nucleat
cell
lesion
site
wherea
lysolecithininduc
lesion
contain
demyelin
axon
present
within
astrocyt
environ
toxin
model
advantag
highli
reproduc
demyelin
lesion
creat
defin
cn
foci
woodruv
number
myelin
mutant
exist
myelin
absent
appreci
reduc
accompani
chang
myelin
structur
oligodendrocyt
number
nave
mutant
prove
invalu
examin
biolog
myelin
benefit
cell
transplant
therapi
myelin
mutant
divid
two
categori
xlink
mutant
myelindefici
md
rat
shake
pup
jimpi
jp
rat
autosom
recess
mutant
shiver
shi
mous
quak
qk
mous
taiep
rat
xlink
mutant
form
biggest
wellcharacter
group
newer
model
induc
oligodendrocyt
death
includ
inject
viral
protein
like
human
endogen
retroviru
herv
glycoproteinsyncitin
retrovir
protein
increasingli
thought
play
role
pathogenesi
ms
altern
genet
strategi
use
induc
anatom
lineagetarget
cell
deplet
use
cremedi
gene
recombin
antoni
et
al
brockschnied
et
al
buch
et
al
christensen
model
particular
advantag
mimic
specif
aspect
ms
lesion
model
suycient
mimic
rang
patholog
present
diseas
immun
model
gener
consid
mimic
diseas
process
pathogenesi
ms
better
toxin
model
although
scarc
evid
trigger
ms
similar
induc
demyelin
model
drawback
immunemedi
demyelin
diyculti
separ
cellular
event
associ
demyelin
repair
mechan
occur
parallel
contrast
demyelin
occur
singl
acut
episod
follow
toxin
inject
cn
allow
demyelin
tempor
separ
regen
event
occur
respons
demyelin
make
toxin
model
particularli
attract
studi
remyelin
biolog
oligodendrocyt
apoptosi
may
major
caus
patholog
ms
subgroup
barnett
prinea
toxin
model
caus
oligodendrocyt
death
target
oligodendrocyt
deplet
model
mimic
aspect
diseas
major
factor
consid
extrapol
experiment
find
studi
ms
model
creat
small
area
demyelin
gener
repair
high
eycienc
pertain
ms
lesion
severalfold
larger
experiment
lesion
therefor
tempor
progress
dynam
repair
experiment
versu
clinic
lesion
predict
significantli
diver
may
implic
remyelin
failur
discuss
later
remyelin
requir
cell
prolifer
highlight
find
xirradi
demyelin
lesion
procedur
elimin
divid
cell
notabl
oligodendrocyt
progenitor
cell
opc
suycient
abolish
remyelin
blakemor
patterson
chari
et
al
origin
oligodendrocyt
undertak
remyelin
controversi
past
two
cell
propos
put
sourc
surviv
oligodendrocyt
demyelin
lesion
opc
opc
group
ubiquit
slowli
divid
potenti
multipot
neural
progenitor
make
roughli
adult
cn
cell
popul
review
polito
reynold
evid
suggest
matur
oligodendrocyt
postmitot
incap
gener
new
oligodendrocyt
crang
et
al
keirstead
blakemor
basi
number
studi
howev
wide
accept
new
myelin
sheath
made
new
oligodendrocyt
deriv
opc
scheme
remyelin
propos
base
observ
repair
experiment
toxininduc
lesion
wherebi
remyelin
occur
two
major
phase
first
recruit
phase
opc
prolifer
order
popul
demyelin
area
opc
subsequ
diverenti
premyelin
oligodendrocyt
contact
demyelin
axon
diverenti
matur
myelin
oligodendrocyt
form
function
myelin
sheathsthi
constitut
diverenti
phase
recruit
diverenti
phase
associ
distinct
time
pattern
express
molecul
notabl
among
rang
growth
factor
newli
gener
myelin
form
result
remyelin
distinct
normal
myelin
form
develop
experiment
analys
show
strike
similar
process
review
franklin
therefor
remyelin
could
consid
recapitul
development
myelin
process
keep
wide
prevail
hypothesi
regen
mechan
recapitul
development
event
despit
demonstr
parallel
kept
mind
development
myelin
occur
normal
order
microenviron
contrast
remyelin
occur
within
disrupt
patholog
microenviron
domin
macrophag
cell
contain
demyelin
axon
within
area
astrocytosi
none
pertain
develop
franklin
remyelin
success
appear
critic
molecular
signal
environ
lesion
shift
one
initi
promot
opc
recruitmentprolifer
one
favor
diverenti
franklin
therefor
perturb
tempor
progress
individu
stage
repair
could
significantli
alter
outcom
repair
process
discuss
section
iv
opc
major
prolif
popul
adult
cn
account
bromodeoxyuridin
brdu
incorpor
cell
spinal
cord
cortex
respect
despit
opc
rel
quiescent
cell
divid
infrequ
slow
rate
divis
polito
reynold
respons
demyelin
cn
trauma
opc
undergo
process
activ
follow
rapid
prolifer
opc
activ
associ
distinct
chang
includ
morpholog
alter
increas
size
upregul
cell
surfac
chondroitin
sulfat
proteoglycan
also
demonstr
increas
gene
express
transcript
factor
associ
development
myelin
opc
wm
normal
express
low
level
bhlh
transcript
factor
homeodomain
transcript
factor
howev
strike
increas
express
restrict
oligodendrocyt
lineag
cell
occur
within
acut
demyelin
le
sion
fig
fan
cy
et
al
coexp
ression
n
opc
appear
necessari
cell
diverenti
myelin
oligodendrocyt
hypothes
express
two
molecul
constitut
genet
switch
convert
rel
quiescent
opc
myelin
oligodendrocyt
level
show
rapid
subsequ
decreas
diverenti
oligodendrocyt
therefor
author
hypothes
express
pattern
could
enabl
distinct
made
opc
activ
particip
repair
opc
quiescent
author
specul
distinct
could
enabl
activ
repair
lesion
distinguish
one
remyelin
failur
occur
follow
activ
opc
undergo
rapid
prolifer
order
popul
demyelin
area
sever
factor
identifi
alon
combin
promot
opc
prolifer
vivo
vitro
includ
plateletderiv
growth
factor
pdgf
fibroblast
growth
factor
glial
growth
factor
pdgf
receptor
express
opc
prolif
respons
demyelin
redwin
armstrong
accompani
increas
express
pdgf
area
demyelin
messersmith
et
al
woodruv
et
al
pdgfa
knockout
mice
show
significantli
reduc
number
opc
oligodendrocyt
accompani
impair
genesi
myelin
fruttig
et
al
convers
pdgfa
overexpress
result
signific
increas
opc
densiti
demyelin
lesion
woodruv
et
al
studi
also
examin
increas
avail
opc
mitogen
associ
enhanc
remyelin
rate
old
rat
signific
diver
observ
transgen
control
anim
despit
increas
opc
number
former
suggest
opc
suppli
within
lesion
may
rate
limit
remyelin
recent
studi
examin
role
individu
signal
pathway
demonstr
distinct
role
vivo
pdgf
remyelin
author
suggest
pdgfr
signal
like
mainli
regul
opc
prolifer
respons
demyelin
predomin
inhibitor
opc
diverenti
murti
et
al
system
administ
neuregulin
express
neuron
also
shown
promot
opc
expans
prevent
opc
diverenti
enhanc
remyelin
experiment
eae
lesion
marchionni
et
al
contrast
direct
administr
ggf
area
toxininduc
demyelin
alter
extent
remyelin
suggest
system
deliveri
may
avect
remyelin
alter
immun
respons
rather
direct
evect
oligodendrocyt
lineag
cell
penderi
et
al
numer
extracellular
intracellular
factor
modul
extent
opc
diverenti
myelin
format
coher
scheme
emerg
far
intric
process
progenitor
diverenti
myelin
oligodendrocyt
regul
numer
transcript
factor
regulatori
molecul
mediat
development
myelin
includ
bhlh
protein
gtx
among
other
role
remyelin
need
elucid
review
franklin
key
nonredund
role
transcript
factor
report
mediat
remyelin
arnett
et
al
repair
toxininduc
demyelin
lesion
brain
spinal
cord
significantli
reduc
knockout
mice
compar
control
recruit
opc
lesion
knockout
mice
appear
normal
cell
fail
diverenti
remyelin
oligodendrocyt
subcellular
local
could
critic
factor
mediat
diverenti
nuclear
express
opc
margin
ms
lesion
suggest
associ
cell
activ
engag
repair
opc
prolifer
involv
growth
factor
regul
opc
diverenti
extens
document
insulinlik
growth
suggest
play
critic
role
process
base
studi
transgen
mice
overexpress
increas
myelin
sheath
thick
number
myelin
axon
increas
number
oligodendrocyt
observ
express
igf
ms
lesion
also
consist
notion
molecul
play
major
role
diverenti
phase
carson
et
al
gveric
et
al
luzi
et
al
ye
et
al
transform
growth
factor
inhibit
pdgfand
opc
prolifer
suggest
import
regul
oligodendrocyt
diverenti
mckinnon
et
al
observ
pattern
time
express
demyelin
lesion
support
idea
molecul
regul
opc
diverenti
repair
sim
et
al
howev
directli
increas
level
mrna
use
adenoviralmedi
gene
deliveri
suycient
increas
extent
oligodendrocytemedi
remyelin
toxininduc
lesion
old
rat
compar
young
one
oleari
et
al
becom
increasingli
clear
electr
activ
axon
axonderiv
signal
neurotransmitt
releas
play
import
role
genesi
surviv
diverenti
oligodendrocyt
induct
development
myelin
review
coman
et
al
block
increas
fire
rate
neuron
respect
inhibit
enhanc
myelin
demeren
et
al
oligodendrocyt
opc
express
rang
ion
channel
neurotransmitt
receptor
activ
inhibit
alter
prolifer
diverenti
cell
myelin
gallo
et
al
opc
also
thought
make
close
contact
node
ranvier
synaps
bergl
et
al
butt
et
al
therefor
well
place
anatom
respond
chang
axon
function
normal
patholog
situat
observ
point
clear
link
electr
activ
myelin
potenti
evect
electr
activ
conduct
block
demyelin
axon
prolifer
diverenti
adult
opc
surround
tissu
yet
establish
inhibitor
oligodendrocyt
diverenti
like
psancam
vitronectin
tenascinsr
jag
express
axon
review
coman
et
al
lend
support
idea
axon
could
play
key
role
regul
properti
oligodendrocyt
lineag
cell
myelin
sever
intracellular
opc
diverenti
factor
also
identifi
cyclindepend
kinas
inhibitor
found
accumul
opc
reach
threshold
appear
inhibit
opc
prolifer
increas
diverenti
durand
rav
also
appear
regul
opc
respons
mitogen
number
opc
recruit
demyelin
areasopc
number
significantli
increas
null
mice
compar
wildtyp
control
crockett
et
al
anoth
recent
studi
demonstr
transmembran
cn
protein
express
oligodendrocyt
could
play
critic
role
diverenti
myelin
author
suggest
molecul
could
repres
import
therapeut
target
demyelin
dysmyelin
disord
mi
et
al
inflamm
undoubtedli
contribut
pathogenesi
demyelin
lesion
ms
howev
consider
evid
support
view
inflammatori
respons
provid
import
stimul
remyelin
remyelin
frequent
associ
promin
inflammatori
respons
experiment
ms
lesion
remyelin
also
observ
occur
eycient
earli
activ
lesion
inflammatori
respons
robust
graca
blakemor
ludwin
rain
wu
one
studi
use
avymetrix
microarray
identifi
chang
gene
express
remyelin
indic
alter
inflammatori
gene
repres
promin
chang
emphas
role
activ
inflammatori
respons
arnett
et
al
furthermor
sever
studi
demonstr
impair
remyelin
absenc
lymphocyt
mhcii
inflammatori
cytokin
macrophag
arnett
et
al
arnett
et
al
bieber
et
al
kotter
et
al
mason
et
al
support
find
antiinflammatori
drug
minocyclin
corticosteroid
dexamethason
methylprednisolon
prednison
significantli
delay
remyelin
toxininduc
demyelin
lesion
chari
et
al
li
et
al
triarhou
herndon
fig
antiinflammatori
agent
appear
act
mainli
inhibit
opc
diverenti
colon
lesion
opc
found
essenti
normal
corticosteroid
cs
treat
anim
agent
perman
impair
repair
properti
myelinogen
cell
normal
level
remyelin
found
increas
surviv
time
follow
treatment
withdraw
chari
et
al
cs
administr
numer
known
benefit
find
obviou
implic
use
antiinflammatori
therapi
ms
rais
possibl
prolong
antiinflammatori
treatment
may
predispos
enhanc
axon
loss
ms
lesion
chari
et
al
fig
chronic
ms
lesion
contain
opc
fail
bind
antibodi
marker
cell
prolifer
suggest
rel
quiescent
popul
lesion
contain
nuclei
one
indic
toward
lower
right
figur
reproduc
permiss
wolswijk
could
inflamma
tion
influen
ce
remyelin
ation
exact
mec
hanism
uncl
ar
present
macrop
hagesmi
cro
glia
suggest
ed
prod
uce
olecul
growt
h
factor
mediat
e
repair
either
direc
tli
act
ivat
astroci
te
prod
uce
rem
yelin
associat
ed
growth
fa
ctor
ad
dition
periton
eal
macropha
ge
vitro
fetal
neu
ron
glia
co
cultur
increas
synth
si
myelin
prot
ein
like
mbp
increa
se
myelin
deposit
loughlin
et
al
nathan
infla
mmation
also
enha
nce
surviv
migra
tion
tran
plant
opc
par
due
upregulati
multipl
factor
implica
ted
ol
igoden
drocyt
developmen
setzu
et
al
tourb
ah
et
al
simila
r
remyelin
ationprom
ote
role
suggest
cell
demi
elin
lesion
bieber
et
al
macrop
hage
play
ajor
role
myelin
deb
ri
cleara
nce
sugg
estion
tha
opc
matur
inhibit
conta
ct
w
ith
myelin
mill
r
inde
introduct
ion
purifi
myelin
demi
elin
lesion
brainst
caus
signific
impair
ment
remyelin
ation
att
ribut
arrest
opc
di
verentia
tion
rath
r
impai
red
recruit
ment
thi
impair
ment
ay
due
physi
cal
restr
iction
contact
betw
een
myelin
ate
oligod
endrocyt
demi
elin
axon
alternat
ive
due
presenc
inhibitori
olecul
myelin
debri
remyelin
ation
regul
com
plex
echan
individ
ual
phase
repair
associa
ted
distinct
time
pattern
express
numer
molec
ule
given
complexit
regulatori
proce
se
promin
ent
heterog
eneiti
pathog
enesi
extent
cell
surv
ival
ms
lesion
clear
succ
repair
influen
ced
seve
ral
interdepen
dent
variab
le
inclu
de
opc
oligoden
drocyt
availa
biliti
lesion
astrocyt
e
macrophag
presenc
demyelin
area
time
coordin
express
regulatori
molecul
abil
axon
opc
remyelin
oligodendrocyt
interact
manner
appropri
success
remyelin
occur
paramet
influenc
age
chari
et
al
gilso
n
blake
sim
et
al
sex
possibl
lesion
size
chari
blakemor
therefor
singl
causal
factor
remyelin
failur
appear
unlik
postul
caus
regen
failur
ms
remain
larg
specul
sever
issu
must
consid
first
given
opc
critic
mediat
remyelin
question
whether
cell
deplet
ms
lesion
crucial
unresolv
one
histopatholog
studi
use
marker
like
pdgfr
suggest
opc
present
chronic
ms
lesion
brain
spinal
cord
equal
higher
number
periplaqu
wm
chang
et
al
scold
et
al
wolswijk
opc
howev
suggest
rel
quiescent
base
failur
label
nuclear
prolifer
antigen
detect
antibodi
fig
lack
oligodendrocyt
center
ms
lesion
suggest
opc
may
incap
diverenti
altern
lesion
environ
lack
factor
stimul
regen
mechan
contain
factor
inhibit
wolswijk
one
studi
examin
specif
possibl
remyelin
fail
due
local
opc
destruct
along
oligodendrocyt
demonstr
chronic
lesion
spinal
cord
ms
patient
contain
signific
number
posit
galc
neg
opc
wolswijk
interpret
observ
kept
mind
curren
tli
impossib
le
dist
uish
opc
tha
surviv
lesion
opc
tha
co
loniz
lesion
surrou
nding
norma
l
tissu
e
fore
observ
abunda
nce
opc
lesion
provid
clue
potenti
destru
ction
earli
stage
lesion
dev
elopmen
studi
port
increasin
g
age
subjec
ts
durat
ion
clinica
l
symp
tom
opc
densiti
declin
ed
signifi
cantli
genesi
new
oligoden
drocyt
appear
ed
increa
singli
impa
ire
lesion
appear
signifi
cantli
repop
ulat
opc
wolswijk
anoth
er
studi
report
tha
posi
tive
cell
could
detect
ed
acut
infl
ammat
lesion
alt
hough
sma
number
lesion
wer
e
examin
ed
studi
ch
ang
et
al
supp
ort
idea
opc
co
uld
kill
ms
le
sion
co
me
demonstra
tion
molecul
like
mog
galc
previous
consid
restrict
oligodendroci
te
also
prese
nt
opc
li
et
al
shi
et
al
autoi
mmuniti
mog
suggest
play
import
role
pathogenesi
ms
lesion
express
molecul
opc
could
theori
result
opc
destruct
find
patient
relapsingremit
ms
synthes
antibodi
opcspecif
surfac
glycoprotein
absent
csf
patient
inact
diseas
niehau
et
al
lend
support
idea
opc
significantli
deplet
along
oligodendrocyt
demyelin
area
repopul
lesion
repairmedi
opc
clearli
constitut
first
step
toward
success
remyelin
influenti
hypothesi
regard
failur
remyelin
ms
exhaust
opc
pool
suggest
opc
becom
deplet
around
lesion
follow
remyelin
howev
one
studi
demonstr
focal
area
experiment
opc
deplet
fulli
repopul
opc
surround
normal
tissu
process
restor
opc
densiti
normal
chari
blakemor
support
find
repeat
episod
demyelin
lead
deplet
opc
pool
impair
remyelin
penderi
et
al
repopul
opcdeplet
area
opc
adjoin
normal
tissu
slow
process
approxim
mmweek
rate
declin
age
due
intrins
chang
opc
chari
et
al
basi
observ
clear
larg
area
demyelin
ms
could
requir
sever
month
becom
complet
repopul
opc
assum
tissu
colon
rate
human
opc
similar
rat
opc
acut
inflamm
appear
provid
major
stimulu
opc
recruit
suggest
abat
inflamm
demyelin
area
time
reduc
drive
remyelin
therebi
caus
repair
failur
word
remyelin
failur
may
occur
due
tempor
mismatch
presenc
remyelinationpromot
environ
arriv
opc
demyelin
area
chari
blakemor
b
would
impli
critic
time
window
exist
interact
opc
demyelin
axon
outsid
likelihood
success
remyelin
significantli
reduc
hypothesi
could
provid
explan
find
remyelin
promin
margin
ms
lesion
core
ie
increas
distanc
lesion
boundari
may
also
account
find
rel
quiescent
opc
popul
present
chronic
lesion
appear
contribut
remyelin
anoth
studi
suggest
presenc
dysfunct
opc
may
inhibit
colon
tissu
opc
normal
tissu
chari
et
al
could
potenti
explain
failur
repopul
lesion
opc
normal
wm
diseas
progress
ms
wolswijk
contrast
studi
examin
distribut
morpholog
oligodendrocyt
chronic
lesion
found
lesion
contain
oligodendrocyt
extend
multipl
process
contact
axon
fail
remyelin
axon
found
dystroph
multipl
swell
author
conclud
remyelin
failur
could
account
either
absenc
opc
failur
gener
oligodendrocyt
instead
suggest
demyelin
axon
longer
recept
remyelin
chang
et
al
recent
review
suggest
demyelin
induc
major
alter
axon
oligodendrogli
signal
event
could
contribut
remyelin
deficit
may
link
reexpress
cell
adhes
molecul
like
psancam
demyelin
axon
ms
patient
inhibitori
evect
remyelin
author
also
specul
modif
domainspecif
aggreg
nodal
perinod
protein
demyelin
disrupt
axogli
interact
domain
could
contribut
repair
failur
coman
et
al
reactiv
astrocytosi
usual
evalu
increas
gfap
immunoreact
earli
respons
demyelin
ayer
et
al
accompani
inflammatori
chang
ms
lesion
hemmer
et
al
character
dens
matrix
astrocyt
process
term
glial
scar
scar
astrocyt
wide
believ
inhibit
remyelin
ensheath
axon
restrict
access
repairmedi
cell
demyelin
axon
grove
et
al
rosen
et
al
studi
indic
astrocyt
may
restrict
migrat
opc
inhibit
remyelin
blakemor
et
al
howev
taiep
mutant
rat
presenc
chronic
demyelin
axon
astrocytosi
appear
repres
signific
barrier
tissu
colon
opc
foot
blakemor
report
suggest
reactiv
astrocyt
could
major
sourc
remyelin
mediat
demyelin
area
franklin
et
al
frost
et
al
hink
franklin
redwin
armstrong
therefor
exact
role
play
reactiv
astrocyt
demyelin
repair
current
far
clear
notchjag
signal
pathway
consist
receptor
ligand
power
inhibitor
opc
diverenti
develop
lesion
brain
ms
patient
contain
elev
level
john
et
al
suggest
notch
pathway
could
potenti
underli
limit
degre
remyelin
observ
ms
recent
demonstr
secretasemedi
inhibit
notch
signal
oligodendrocyt
mice
eae
could
significantli
promot
remyelin
reduc
axon
damag
cn
accompani
enhanc
clinic
recoveri
jurynczyk
et
al
molecul
like
neuregulin
famili
ligand
exert
trophic
evect
neuron
glia
appear
necessari
normal
oligodendrocyt
develop
astrocytederiv
neuregulin
dramat
reduc
chronic
activ
lesion
reduc
express
also
suggest
contribut
pauciti
remyelin
ms
lesion
viehov
et
al
demonstr
recent
glycosaminoglycan
hyaluronan
accumul
ms
lesion
mice
induc
eae
hyaluronan
found
inhibit
remyelin
experiment
demyelin
lesion
interestingli
opc
found
colon
lesion
appear
matur
myelin
oligodendrocyt
area
hyaluronan
express
back
et
al
identif
molecul
demyelin
area
aid
defin
key
therapeut
target
enhanc
remyelin
clinic
integr
current
hypothes
dysregul
hypothesi
suggest
remyelin
may
fail
complex
signal
environ
within
lesion
becom
inappropri
regul
dysregul
therefor
remyelin
may
fail
precis
coordin
variou
cellular
event
necessari
success
remyelin
lost
demyelin
area
fig
franklin
factor
predict
contribut
dysregul
increas
evid
link
absenc
myelin
develop
irrevers
neurolog
deficit
ms
clear
achiev
widespread
remyelin
axon
constitut
major
compon
futur
therapi
aim
limit
neurolog
disabl
restor
function
demyelin
diseas
along
diseasemodifi
neuroprotect
strategi
strategi
enhanc
remyelin
fall
two
broad
categori
remyelin
ms
lesion
appear
fail
incomplet
potenti
strategi
repair
ms
lesion
enhanc
natur
occur
regen
mechan
detail
previou
section
number
molecul
diagram
illustr
remyelin
involv
complex
sequenc
tightli
coordin
event
dysregul
result
remyelin
impair
respons
demyelin
insult
myelin
axon
undergo
demyelin
gener
myelin
debri
demyelin
caus
activ
resid
astrocyt
microglia
activ
astrocyt
microglia
produc
factor
act
recruit
monocyt
vasculatur
microglia
recruit
monocyt
diverenti
macrophag
activ
astrocyt
macrophag
produc
factor
mutual
activ
result
activ
produc
growth
factor
act
opc
alter
prolifer
diverenti
macrophag
remov
myelin
debri
function
benefici
remyelin
influenc
factor
produc
astrocyt
macrophag
recruit
opc
engag
demyelin
axon
diverenti
remyelin
oligodendrocyt
modifi
permiss
franklin
ident
ifi
includin
g
growth
factor
tran
cription
factor
cell
adhes
olecul
present
potenti
therapeu
tic
target
enh
anc
rem
yelin
althoug
h
attract
prin
cipl
seve
ral
cha
lleng
confr
ont
strateg
given
tha
regu
lation
rem
yelin
complex
multifa
ctorial
proce
ident
ific
releva
nt
molecul
enhanc
repair
critic
thi
co
mplicat
con
ider
redund
anci
regul
atori
mechan
ism
media
te
rem
yelin
extens
variabil
iti
obser
ved
occur
ms
lesion
rais
im
portant
issu
lation
nat
ure
time
mode
deliv
eri
thera
peutic
agent
individ
ual
pati
nt
evec
tive
targ
ted
deliv
thera
peutic
agen
ts
multifoc
site
demi
elinati
may
ess
ntial
order
avoid
nonspecif
side
e
vect
system
deliv
eryth
e
use
new
drugbiom
oleculeta
rgete
strateg
iestechn
olog
could
prove
use
gard
antibodi
therapi
interestingli
studi
show
immunoglobulin
gener
prepara
tion
inta
ct
igg
molec
ule
promot
rem
yelin
warrington
et
al
view
trebst
stangel
mecha
nism
immunoglobulin
enhanc
repair
clear
current
postul
mechan
divid
two
categori
direct
via
evect
opc
modifi
prolifer
migrat
diverenti
oligodendrocyt
rescu
cell
death
indirect
via
immunomodulatori
role
decreas
inflammatori
damag
modifi
cytokin
releas
phagocytosi
lesion
altern
strategi
enhanc
remyelin
introduc
myelinform
cell
area
demyelin
sever
cell
type
immatur
adult
identifi
achiev
extens
remyelin
restor
saltatori
conduct
experiment
demyelin
lesion
myelin
mutant
includ
opc
schwann
cell
olfactori
ensheath
cell
oec
well
variou
categori
stem
cell
like
neural
stem
cell
nsc
embryon
stem
cell
esc
bone
marrowderiv
stem
cell
bmsc
derivativesthes
subject
number
excel
review
duboisdalcq
et
al
duncan
ibrahim
et
al
keirstead
tepavcev
blakemor
fig
numer
issu
need
consid
evalu
clinic
feasibl
benefit
cell
transplantationbas
strategi
ms
includ
possibl
transplant
cell
may
turn
becom
target
demyelin
patholog
abil
transplant
popul
prolifer
diverenti
suycient
number
mediat
remyelin
myelin
potenti
gener
appear
depend
degre
enrich
immatur
cell
cell
prepar
esc
particularli
attract
regard
due
capac
unlimit
expans
vitro
broad
diverenti
potenti
includ
diverenti
multipot
neural
precursor
opc
amen
genet
engin
keirstead
nistor
et
al
studi
shown
supernumerari
transplant
opc
surviv
prolifer
migrat
adult
cn
franklin
et
al
oleari
blakemor
indic
consider
deplet
resid
opc
popul
prerequisit
introduc
signific
number
opc
adult
cn
tissu
chari
et
al
may
repres
problem
lesion
opc
deplet
occur
along
oligodendrocyt
loss
howev
dysfunct
opc
appear
inhibit
tissu
repopul
new
opc
chari
et
al
remain
establish
transplantderiv
opc
fact
mediat
repair
lesion
contain
signific
number
endogen
dysfunct
opc
astrogliosi
patholog
hallmark
chronic
ms
lesion
abil
transplant
cell
surviv
within
astroglios
area
key
oec
schwann
cell
shown
surviv
area
astrocytosi
barnett
riddel
clear
extent
oec
expand
indefinit
cultur
opc
hand
possess
abil
colon
area
astrocytosi
caveat
prior
deplet
endogen
opc
popul
presenc
acut
inflammatori
environ
critic
transplant
surviv
foot
blakemor
multifoc
demyelin
anoth
key
featur
ms
abil
transplant
cell
migrat
within
cn
may
import
unless
feasibl
introduc
cell
directli
lesion
multipot
nsc
inject
intraven
intraventricularli
enter
area
demyelin
gener
myelin
oligodendrocyt
mediat
function
recoveri
possibl
cell
express
rang
inflammatori
molecul
like
adhes
molecul
cytokin
chemokin
home
behavior
make
attract
candid
mediat
target
repair
multifoc
lesion
addit
cell
shown
exert
signific
antiinflammatori
evect
reduc
astrocytosi
demyelin
area
multipot
nsc
isol
human
subcort
wm
cell
maintain
vitro
prior
transplant
give
rise
neuron
glia
transplant
rodent
cn
nune
et
al
given
inflamm
appear
benefici
remyelin
transplant
surviv
import
establish
evect
common
antiinflammatori
immunomodulatori
treatment
use
ms
treatment
transplant
surviv
repair
critic
genet
stabil
safeti
transplant
cell
includ
elimin
pathogen
tumorigen
potenti
establish
prior
transplant
potenti
reject
transplant
cell
need
tissuetyp
match
must
taken
account
number
ongo
ethic
polit
issu
relat
deriv
cell
transplant
seriou
impact
therapi
advanc
clinic
trial
addit
mani
practic
concern
surgic
introduc
cell
neural
tissu
includ
consequ
disrupt
bloodbrain
barrier
possibl
induc
hemorrhag
transplant
site
potenti
expens
associ
multipl
surgic
inject
introduc
transplant
cell
multifoc
lesion
iv
signific
challeng
associ
accur
target
transplant
cell
inaccess
cn
lesion
site
risk
induc
csf
occlus
emboli
introduc
cell
intraventricularli
intraven
clear
therefor
benefit
rang
therapeut
strategi
demonstr
experiment
condit
translat
approach
clinic
set
constitut
major
object
futur
studi
